EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics

Danielle Bar, Felix Pavlotsky, Aviv Barzilai, Sharon Baum

Dermatologic Therapy · 2026-01 · 2026 (1)

DOI: 10.1155/dth/2037939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 09.06.2026. Verfasst von Danielle Bar und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biologic therapy in psoriasis raises concerns regarding COVID‐19 infection risk and vaccine response, yet real‐world data remain limited.

Objective

To evaluate COVID‐19 infection rates, clinical severity, and vaccination response among biologic‐treated patients with psoriasis during the COVID‐19 pandemic.

Methods

This cohort study included 12,306 patients with psoriasis followed at a tertiary medical center between March 2020 and May 2023. Primary outcomes included estimated SARS‐CoV‐2 infection rates, hospitalization, ICU admission, mortality, and a composite severe COVID‐19 outcome (hospitalization, ICU admission, or death).

Results

Based on national seroprevalence‐adjusted rates, infection occurred in 673 of 962 biologic‐treated patients (70.0%) and 7657 of 11,344 nonbiologic patients (67.5%) ( p = 0.18). Hospitalization was more frequent among biologic‐treated patients (45.2% vs 25.1%; p < 0.001), while ICU admission rates were comparable (2.6% vs 2.0%; p = 0.41). Mortality was significantly lower in the biologic group (6.3% vs 12.1%; p < 0.001).

Conclusions

Biologic therapy in psoriasis was not associated with increased susceptibility to SARS‐CoV‐2 infection or impaired vaccine response.

Zitieren

APA

Bar, D., Pavlotsky, F., Barzilai, A., & Baum, S. (2026). COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/2037939

Vancouver

Bar D, Pavlotsky F, Barzilai A, Baum S. COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/2037939

BibTeX
@article{Bar2026,
  author = {Bar, Danielle and Pavlotsky, Felix and Barzilai, Aviv and Baum, Sharon},
  title = {COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics},
  journal = {Dermatologic Therapy},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/dth/2037939}
}
Kostenlos starten →